Abiopharma

🔍 COKE MICHAEL A (Director)

Company: Broadstone Net Lease, Inc. (BNL)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 4,987 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 62,950.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Family Trust | shares_owned_after: 22,952.00 | Footnotes: F3

Footnotes:

• F1: On May 1, 2026, Broadstone Net Lease, Inc. (the "Issuer") granted the reporting person an equity award consisting of 4,987 shares of restricted stock pursuant to the Issuer's non-employee director compensation policy (the "Policy") and 2020 Omnibus Equity Incentive Plan. Such shares of restricted stock will vest in full on the earlier of (i) May 1, 2027; and (ii) the date of the Issuer's next annual meeting of stockholders, provided that the next annual meeting of stockholders is at least 50 weeks after the date of the Issuer's 2027 annual meeting of stockholders.
• F2: This amount includes 4,987 shares of unvested restricted stock.
• F3: Shares held by a trust of which the reporting person is co-trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.